150 related articles for article (PubMed ID: 31719570)
1. Computational design and characterization of nanobody-derived peptides that stabilize the active conformation of the β
Sencanski M; Glisic S; Šnajder M; Veljkovic N; Poklar Ulrih N; Mavri J; Vrecl M
Sci Rep; 2019 Nov; 9(1):16555. PubMed ID: 31719570
[TBL] [Abstract][Full Text] [Related]
2. Computational Modeling and Characterization of Peptides Derived from Nanobody Complementary-Determining Region 2 (CDR2) Targeting Active-State Conformation of the β
Sencanski M; Glisic S; Kubale V; Cotman M; Mavri J; Vrecl M
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672440
[TBL] [Abstract][Full Text] [Related]
3. Rational Design of Nanobody80 Loop Peptidomimetics: Towards Biased β
Martin C; Moors SLC; Danielsen M; Betti C; Fabris C; Sejer Pedersen D; Pardon E; Peyressatre M; Fehér K; Martins JC; Mosolff Mathiesen J; Morris MC; Devoogdt N; Caveliers V; De Proft F; Steyaert J; Ballet S
Chemistry; 2017 Jul; 23(40):9632-9640. PubMed ID: 28449310
[TBL] [Abstract][Full Text] [Related]
4. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
Plazinska A; Kolinski M; Wainer IW; Jozwiak K
J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
[TBL] [Abstract][Full Text] [Related]
5. Regulation of β2-adrenergic receptor function by conformationally selective single-domain intrabodies.
Staus DP; Wingler LM; Strachan RT; Rasmussen SG; Pardon E; Ahn S; Steyaert J; Kobilka BK; Lefkowitz RJ
Mol Pharmacol; 2014 Mar; 85(3):472-81. PubMed ID: 24319111
[TBL] [Abstract][Full Text] [Related]
6. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective binding of agonists to the β
Plazinska A; Plazinski W
Mol Biosyst; 2017 May; 13(5):910-920. PubMed ID: 28338133
[TBL] [Abstract][Full Text] [Related]
9. Characterization of porcine beta1- and beta2-adrenergic receptors in heart, skeletal muscle, and adipose tissue, and the identification of an atypical beta-adrenergic binding site.
Sillence MN; Hooper J; Zhou GH; Liu Q; Munn KJ
J Anim Sci; 2005 Oct; 83(10):2339-48. PubMed ID: 16160045
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the NPxxY motif stabilize pharmacologically distinct conformational states of the α
Ragnarsson L; Andersson Å; Thomas WG; Lewis RJ
Sci Signal; 2019 Mar; 12(572):. PubMed ID: 30862702
[TBL] [Abstract][Full Text] [Related]
11. Fast, metadynamics-based method for prediction of the stereochemistry-dependent relative free energies of ligand-receptor interactions.
Plazinska A; Plazinski W; Jozwiak K
J Comput Chem; 2014 Apr; 35(11):876-82. PubMed ID: 24615679
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
Yuzlenko O; Kieć-Kononowicz K
J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of a direct interaction between β2-adrenergic receptor and insulin receptor by BRET and bioinformatics.
Mandić M; Drinovec L; Glisic S; Veljkovic N; Nøhr J; Vrecl M
PLoS One; 2014; 9(11):e112664. PubMed ID: 25401701
[TBL] [Abstract][Full Text] [Related]
14. Search for β2 adrenergic receptor ligands by virtual screening via grid computing and investigation of binding modes by docking and molecular dynamics simulations.
Bai Q; Shao Y; Pan D; Zhang Y; Liu H; Yao X
PLoS One; 2014; 9(9):e107837. PubMed ID: 25229694
[TBL] [Abstract][Full Text] [Related]
15. Functional activity of antibodies at the bovine beta2-adrenoceptor.
Hill RA; Hoey AJ; Sillence MN
J Anim Sci; 1998 Jun; 76(6):1651-61. PubMed ID: 9655586
[TBL] [Abstract][Full Text] [Related]
16. Ligand-binding affinity of alternative conformers of human β
Dilcan G; Doruker P; Akten ED
Chem Biol Drug Des; 2019 May; 93(5):883-899. PubMed ID: 30637937
[TBL] [Abstract][Full Text] [Related]
17. Effect of linker length and composition on heterobivalent ligand-mediated receptor cross-talk between the A1 adenosine and β2 adrenergic receptors.
Barlow N; Baker SP; Scammells PJ
ChemMedChem; 2013 Dec; 8(12):2036-46. PubMed ID: 24106065
[TBL] [Abstract][Full Text] [Related]
18. Agonist binding by the β2-adrenergic receptor: an effect of receptor conformation on ligand association-dissociation characteristics.
Plazinska A; Plazinski W; Jozwiak K
Eur Biophys J; 2015 Apr; 44(3):149-63. PubMed ID: 25726162
[TBL] [Abstract][Full Text] [Related]
19. β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression.
Wan C; Gong C; Zhang H; Hua L; Li X; Chen X; Chen Y; Ding X; He S; Cao W; Wang Y; Fan S; Xiao Y; Zhou G; Shen A
Cancer Lett; 2016 Apr; 373(1):67-76. PubMed ID: 26803058
[TBL] [Abstract][Full Text] [Related]
20. The third intracellular loop and the carboxyl terminus of beta2-adrenergic receptor confer spontaneous activity of the receptor.
Chakir K; Xiang Y; Yang D; Zhang SJ; Cheng H; Kobilka BK; Xiao RP
Mol Pharmacol; 2003 Nov; 64(5):1048-58. PubMed ID: 14573753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]